You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › July › 16
Lilly
9 days ago
The world’s largest drugmaker is betting big on preventive medicines—and learning from big tech
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction ⊕
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.
page 1 of 1